Company intelligence / Profile preview

GIC Management Services

Singapore, Singapore

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

GIC is a leading global investment firm established in 1981 to manage Singapore's foreign reserves. While not a drug development company itself, GIC is one of the most significant institutional investors in the global life sciences, biotechnology, and healthcare sectors. Through its dedicated Healthcare Business Group, the firm provides long-term capital to innovative companies across the healthcare value chain, including biopharmaceuticals, medical technology, and healthcare services. Notable investments in the sector include significant stakes in companies such as BioNTech, WuXi AppTec, and Esco Lifesciences.

Industry: Investors

Partnerships

Temasek HoldingsARCH Venture PartnersWellington Management

Beyond the preview

Go deeper on GIC Management Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GIC Management Services.

Explore the full profile